Total Migraine freedom for breath powered intranasal delivery of 22 mg Sumatriptan Powder (Avp-825) Versus 100 mg oral sumatriptan from the compass study of acute treatment of Migraine
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1627
https://www.valueinhealthjournal.com/article/S1098-3015(15)01684-8/fulltext
Title :
Total Migraine freedom for breath powered intranasal delivery of 22 mg Sumatriptan Powder (Avp-825) Versus 100 mg oral sumatriptan from the compass study of acute treatment of Migraine
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01684-8&doi=10.1016/j.jval.2015.03.1627
First page :
A278
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
1096